Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Hematological Infection 1Gram-Negative Bacterial Infections 1Colorectal Neoplasms 1Anastomotic Leak 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 37Zoledronic Acid 34Letrozole 34Sodium Chloride 33Carboplatin 33Bupivacaine 31Bevacizumab 31Docetaxel 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Gemcitabine 22Oxaliplatin 21Morphine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Colistin × Clear all
NCT03397914 2020-09-16

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

National Cancer Institute, Egypt

Phase 4 Completed
70 enrolled

Neoplasms, Gram-Negative Bacterial Infections

NCT01740947 2018-11-09

SELECT

Amsterdam UMC, location VUmc

Phase 4 Terminated
485 enrolled
Gastrointestinal

Colorectal Neoplasms, Anastomotic Leak

NCT02966457 2017-12-28

DEHAM

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology

Phase 4 Completed
62 enrolled

Hematological Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡